Table 2. Multivariate COX models and Fine-Gray models for survival analysis.
COX-CSS | COX-OS | FGM-CSS | |||||
---|---|---|---|---|---|---|---|
no-ACRT | HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
Model 1 | Ref | 1.111 (0.962–1.283) | 0.154 | 1.010 (0.885–1.153) | 0.883 | 1.135 (0.984–1.308) | 0.082 |
Model 2 | Ref | 1.105 (0.957–1.277) | 0.174 | 1.009 (0.884–1.152) | 0.891 | 1.127 (0.977–1.299) | 0.100 |
Model 3 | Ref | 1.102 (0.954–1.274) | 0.187 | 1.010 (0.884–1.154) | 0.882 | 1.124 (0.975–1.297) | 0.110 |
Model 4 | Ref | 1.097 (0.949–1.268) | 0.211 | 1.007 (0.881–1.150) | 0.920 | 1.125 (0.975–1.297) | 0.110 |
Model 5 | Ref | 1.087 (0.940–1.257) | 0.259 | 0.998 (0.874–1.141) | 0.982 | 1.118 (0.969–1.290) | 0.130 |
Model 1: no adjustment
Model 2: adjusted for age, gender, year of diagnosis
Model 3: model 2 + T classification, N classification, TNM stage
Model 4: model 3 + tumor histology, histological grade
Model 5: model 4 + race, marital status.
no-ACRT group was set as a reference.
ACRT, adjuvant chemotherapy or radiotherapy; Ref, reference; CSS, cancer-specific survival; OS, overall survival; FGM: Fine-Gray model; HR, hazard ratio; CI, confidence interval.